Skip Navigation


NDT Advance Access originally published online on April 12, 2005
Nephrology Dialysis Transplantation 2005 20(6):1275-1276; doi:10.1093/ndt/gfh826
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/1275    most recent
gfh826v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Labaye, J.
Right arrow Articles by Noël, L.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labaye, J.
Right arrow Articles by Noël, L.-H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Letter

Renal toxicity of Oxaliplatin

The first 10% of the full text of this article appears below.

Sir,

Oxaliplatin is an antitumoral agent derived from platinum (trans-1,2-diammino-cylo-hexane-platinum) with cytotoxic activity against a number of solid tumours, including colorectal cancer and metastatic ovarian carcinoma. Renal side-effects are unclear. We report the second case of acute renal failure following the use of oxaliplatin.

A 69-year-old woman was referred to . . . [Full Text of this Article]

Jacques Labaye1, Damien Sarret1, Christan Duvic1, Michel Hérody1, Francis Didelot1, Georges Nédélec1 and Laure-Hélène Noël2

1 Armed Forces Hospital of Val de Grâce Paris France2 INSERM U507 Hôpital Necker (AP-HP) Paris France Email: jah.labaye@wanadoo.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NDT PlusHome page
N. T. Phan, A. E. Heng, A. Lautrette, J. L. Kemeny, and B. Souweine
Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis
NDT Plus, June 1, 2009; 2(3): 254 - 256.
[Full Text] [PDF]

Home page
 Ann OncolHome page
M Linch, D Cunningham, O Mingo, A Stiles, and W. Farquhar-Smith
Renal tubular acidosis due to oxaliplatin
Ann. Onc., April 1, 2007; 18(4): 805 - 806.
[Full Text] [PDF]